Financhill
Sell
37

VKTX Quote, Financials, Valuation and Earnings

Last price:
$29.73
Seasonality move :
19.69%
Day range:
$27.59 - $30.14
52-week range:
$24.41 - $89.10
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
3.77x
Volume:
7.6M
Avg. volume:
5.2M
1-year change:
-55.96%
Market cap:
$3.3B
Revenue:
--
EPS (TTM):
-$1.00

VKTX Analysts' Consensus Rating

The 10 analysts providing 12-month price projections for Viking Therapeutics shares anticipate an average target of $99.29, ranging from a low estimate of $38.00 to a high estimate of $164.00. This average target implies a growth of 236.02% compared to the current stock price of $29.55.

Consensus Price Target

$99.29

Highest Price Target

$164.00

Lowest Price Target

$38.00

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 8 9 9

Hold 0 1 1

Sell 0 0 0
Consensus Buy Buy Buy

VKTX Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

3 Safest Stocks to Buy Now
3 Safest Stocks to Buy Now

With the S&P 500 now in correction and stocks selling…

Tesla Stock: The Bear Case
Tesla Stock: The Bear Case

The recent stock market drop has been a punishing time…

Is VUG a Good ETF to Buy?
Is VUG a Good ETF to Buy?

For the last few years, earnings growth from the tech…

Stock Ideas

Sell
46
Is AAPL Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 36x

Sell
48
Is MSFT Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 32x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 39x

Alerts

Sell
50
TREE alert for Mar 13

LendingTree [TREE] is up 1.53% over the past day.

Buy
57
INOD alert for Mar 13

Innodata [INOD] is down 7.4% over the past day.

Sell
40
VIST alert for Mar 13

Vista Energy SAB de CV [VIST] is up 0.36% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock